|
1
|
Aygun B and Odame I: A global perspective
on sickle cell disease. Pediatr Blood Cancer. 59:386–390.
2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ware RE, de Montalembert M, Tshilolo L and
Abboud MR: Sickle cell disease. Lancet. 390:311–323.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shet AS, Lizarralde-Iragorri MA and Naik
RP: The molecular basis for the prothrombotic state in sickle cell
disease. Haematologica. 105:2368–2379. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Glassberg J: Evidence-based management of
sickle cell disease in the emergency department. Emerg Med Pract.
13:1–20; quiz 20. 2011.PubMed/NCBI
|
|
5
|
Paul RN, Castro OL, Aggarwal A and Oneal
PA: Acute chest syndrome: Sickle cell disease. Eur J Haematol.
87:191–207. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vichinsky EP, Neumayr LD, Earles AN,
Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V,
Bellevue R, et al: Causes and outcomes of the acute chest syndrome
in sickle cell disease. National acute chest syndrome study group.
N Engl J Med. 342:1855–1865. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
McCloskey KA, Meenan J, Hall R and
Tsitsikas DA: COVID-19 infection and sickle cell disease: A UK
centre experience. Br J Haematol. 190:e57–e58. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Beerkens F, John M, Puliafito B, Corbett
V, Edwards C and Tremblay D: COVID-19 pneumonia as a cause of acute
chest syndrome in an adult sickle cell patient. Am J Hematol.
95:E154–E156. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Giannis D, Ziogas IA and Gianni P:
Coagulation disorders in coronavirus infected patients: COVID-19,
SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol.
127(104362)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Varga Z, Flammer AJ, Steiger P, Haberecker
M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka
F and Moch H: Endothelial cell infection and endotheliitis in
COVID-19. Lancet. 395:1417–1418. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
White RH and Keenan CR: Effects of race
and ethnicity on the incidence of venous thromboembolism. Thromb
Res. 123 (Suppl 4):S11–S17. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Teulier M, Elabbadi A, Gerotziafas G,
Lionnet F, Voiriot G and Fartoukh M: Severe COVID-19 with acute
respiratory distress syndrome (ARDS) in a sickle cell disease adult
patient: Case report. BMC Pulm Med. 21(46)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Silva-Pinto AC, Santos-Oliveira L, Santos
FLS, Kashima Haddad S, De Santis GC and do Tocantins Calado R:
COVID-19 infection in sickle cell patients in a developing Country:
A case series. Acta Haematol. 145:1–4. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hussain FA, Njoku FU, Saraf SL, Molokie
RE, Gordeuk VR and Han J: COVID-19 infection in patients with
sickle cell disease. Br J Haematol. 189:851–852. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Arlet JB, de Luna G, Khimoud D, Odièvre
MH, de Montalembert M, Joseph L, Chantalat-Auger C, Flamarion E,
Bartolucci P, Lionnet F, et al: Prognosis of patients with sickle
cell disease and COVID-19: A French experience. Lancet Haematol.
7:e632–e634. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Balanchivadze N, Kudirka AA, Askar S,
Almadhoun K, Kuriakose P, Fadel R and Dabak V: Impact of COVID-19
infection on 24 patients with sickle cell disease. One center urban
experience, Detroit, MI, USA. Hemoglobin. 44:284–289.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen-Goodspeed A and Idowu M: COVID-19
presentation in patients with sickle cell disease: A case series.
Am J Case Rep. 22(e931758)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Telfer P, De la Fuente J, Sohal M, Brown
R, Eleftheriou P, Roy N, Piel FB, Chakravorty S, Gardner K, Velangi
M, et al: Real-time national survey of COVID-19 in hemoglobinopathy
and rare inherited anemia patients. Haematologica. 105:2651–2654.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Arlet JB, Lionnet F, Khimoud D, Joseph L,
de Montalembert M, Morisset S, Garou A, Cannas G, Cougoul P,
Guitton C, et al: Risk factors for severe COVID-19 in hospitalized
sickle cell disease patients: A study of 319 patients in France. Am
J Hematol. 97:E86–E91. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Panepinto JA, Brandow A, Mucalo L, Yusuf
F, Singh A, Taylor B, Woods K, Payne AB, Peacock G and Schieve LA:
Coronavirus disease among persons with sickle cell disease, United
States, March 20-May 21, 2020. Emerg Infect Dis. 26:2473–2476.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Minniti CP, Zaidi AU, Nouraie M, Manwani
D, Crouch GD, Crouch AS, Callaghan MU, Carpenter S, Jacobs C, Han
J, et al: Clinical predictors of poor outcomes in patients with
sickle cell disease and COVID-19 infection. Blood Adv. 5:207–215.
2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Singh A, Brandow AM and Panepinto JA:
COVID-19 in individuals with sickle cell disease/trait compared
with other Black individuals. Blood Adv. 5:1915–1921.
2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Clift AK, Saatci D, Coupland CAC,
Dambha-Miller H and Hippisley-Cox J: International Investigator
Group for Ethnicity and COVID-19. Sickle cell disorders and severe
COVID-19 outcomes: A cohort study. Ann Intern Med. 174:1483–1487.
2021.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Mucalo L, Brandow AM, Dasgupta M, Mason
SF, Simpson PM, Singh A, Taylor BW, Woods KJ, Yusuf FI and
Panepinto JA: Comorbidities are risk factors for hospitalization
and serious COVID-19 illness in children and adults with sickle
cell disease. Blood Adv. 5:2717–2724. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Menapace LA and Thein SL: COVID-19 and
sickle cell disease. Haematologica. 105:2501–2504. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Griffin JB, Haddix M, Danza P, Fisher R,
Koo TH, Traub E, Gounder P, Jarashow C and Balter S: SARS-CoV-2
infections and hospitalizations among persons aged ≥16 Years, by
vaccination status-los angeles county, California, May 1-July 25,
2021. MMWR Morb Mortal Wkly Rep. 70:1170–1176. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jan H, Waheeb A, AlAhwal H, Almohammadi A,
Al-Marzouki A, Barefah A, Bahashawan S and Radhwi O: COVID-19
vaccine perception and hesitancy among patients with sickle cell
disease in the western region of Saudi Arabia. Cureus.
14(e21026)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Guillon P, Clément M, Sébille V, Rivain
JG, Chou CF, Ruvoën-Clouet N and Le Pendu J: Inhibition of the
interaction between the SARS-CoV spike protein and its cellular
receptor by anti-histo-blood group antibodies. Glycobiology.
18:1085–1093. 2008.PubMed/NCBI View Article : Google Scholar
|
